Atlas Trials

Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies

Clinical trial NCT01117623 · COMPLETED

Trial details

NCT number
NCT01117623
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasm
Start date
2007-02-01
Primary completion
2013-11-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.